Truist Financial Keeps Their Buy Rating on Sangamo Biosciences (SGMO)
Truist Financial analyst Nicole Germino maintained a Buy rating on Sangamo Biosciences (SGMO – Research Report) today and set a price target of ...
Sangamo price target lowered to $5 from $7 at Truist
Truist analyst Nicole Germino lowered the firm’s price target on Sangamo (SGMO) to $5 from $7 and keeps a Buy rating on the shares. The firm ...
Truist cuts Sangamo stock target to $5, maintains Buy rating
Truist Securities adjusted its outlook for Sangamo BioSciences, reducing the price target on the company's shares to $5 from ...
The New York Times16h
New York Times - Top Stories
House G.O.P. Floats Medicaid Cuts and More to Finance Trump’s Huge Agenda President Trump wants a massive tax cut and immigration crackdown bill. Republicans must decide what to cut to help pay ...